Implicity Raises $23M in Series A Funding

implicity

Implicity, a Cambridge, MA-based provider of a remote patient monitoring and cardiac data management solutions, raised $23M in Series A funding.

The round was led by Crédit Mutuel Innovation and Bpifrance, with participation from BNP Paribas Development, Serena, XAnge and Karista.

The company intends to use the funds to:

  • Increase the company’s market presence in the US and support expansion into new markets           
  • Develop additional medical device software to strengthen the technological leadership of the company

Led by CEO Dr. Arnaud Rosier, Implicity is a software company that provides a universal cardiac remote monitoring and research platform to clinics and service companies. Its AI-based technology and cardiac data management solutions enable healthcare professionals around the world to have a more holistic approach to caring for cardiac patients. This new funding comes months after the company received FDA clearance for a novel AI algorithm that analyzes ECG episodes from Implantable Loop Recorders (ILRs).

IMPLICITY® covers more than 60,000 patients in 100 medical facilities across the United States and Europe. 

FinSMEs

27/04/2022